{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T19:19:20Z","timestamp":1792351160284,"version":"4.4.0"},"reference-count":80,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","cell.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Pharmacological Sciences"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.tips.2015.11.008","type":"journal-article","created":{"date-parts":[[2015,12,22]],"date-time":"2015-12-22T04:44:56Z","timestamp":1450759496000},"page":"231-241","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":101,"title":["Antibody-Based Biologics and Their Promise to Combat Staphylococcus aureus Infections"],"prefix":"10.1016","volume":"37","author":[{"given":"William E.","family":"Sause","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter T.","family":"Buckley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William R.","family":"Strohl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Simon","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor J.","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tips.2015.11.008_bib0400","first-page":"1970","article-title":"National burden of invasive methicillin-resistant Staphylococcus aureus infections United States, 2011","volume":"173","author":"Dantes","year":"2013","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.tips.2015.11.008_bib0405","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1086\/596743","article-title":"Anti-staphylococcal humoral immune response in persistent nasal carriers and noncarriers of Staphylococcus aureus","volume":"199","author":"Verkaik","year":"2009","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.tips.2015.11.008_bib0410","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1128\/CDLI.12.3.387-398.2005","article-title":"Comparison of antibody repertoires against Staphylococcus aureus in healthy individuals and in acutely infected patients","volume":"12","author":"Dryla","year":"2005","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.tips.2015.11.008_bib0415","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1086\/503048","article-title":"Staphylococcus aureus carriers neutralize superantigens by antibodies specific for their colonizing strain: a potential explanation for their improved prognosis in severe sepsis","volume":"193","author":"Holtfreter","year":"2006","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.tips.2015.11.008_bib0420","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1146\/annurev-micro-092412-155746","article-title":"Neutrophils versus Staphylococcus aureus: a biological tug of war","volume":"67","author":"Spaan","year":"2013","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.tips.2015.11.008_bib0425","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nrmicro3521","article-title":"Staphylococcal manipulation of host immune responses","volume":"13","author":"Thammavongsa","year":"2015","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.tips.2015.11.008_bib0430","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3389\/fimmu.2014.00109","article-title":"Covering all the bases: preclinical development of an effective Staphylococcus aureus vaccine","volume":"5","author":"Scully","year":"2014","journal-title":"Front. Immunol."},{"issue":"Suppl. 5","key":"10.1016\/j.tips.2015.11.008_bib0435","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/1469-0691.12570","article-title":"Where does a Staphylococcus aureus vaccine stand?","volume":"20","author":"Fowler","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.tips.2015.11.008_bib0440","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1016\/j.vaccine.2013.04.002","article-title":"Vaccine review: \u2018Staphyloccocus aureus vaccines: problems and prospects\u2019","volume":"31","author":"Jansen","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.tips.2015.11.008_bib0445","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/cid\/cir828","article-title":"Progress toward a Staphylococcus aureus vaccine","volume":"54","author":"Daum","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.tips.2015.11.008_bib0450","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nrmicro3308","article-title":"Models matter: the search for an effective Staphylococcus aureus vaccine","volume":"12","author":"Salgado-Pabon","year":"2014","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.tips.2015.11.008_bib0455","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/sj.jp.7211496","article-title":"A blinded, randomized, multicenter study of an intravenous Staphylococcus aureus immune globulin","volume":"26","author":"Benjamin","year":"2006","journal-title":"J. Perinatol."},{"key":"10.1016\/j.tips.2015.11.008_bib0460","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1128\/IAI.64.5.1659-1665.1996","article-title":"A Staphylococcus aureus capsular polysaccharide (CP) vaccine and CP-specific antibodies protect mice against bacterial challenge","volume":"64","author":"Fattom","year":"1996","journal-title":"Infect. Immun."},{"key":"10.1016\/j.tips.2015.11.008_bib0465","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1128\/JCM.01572-06","article-title":"Identification of the capsular polysaccharides in Staphylococcus aureus clinical isolates by PCR and agglutination tests","volume":"45","author":"Verdier","year":"2007","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.tips.2015.11.008_bib0470","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1111\/j.1365-2958.2005.04978.x","article-title":"Molecular characterization of the capsule locus from non-typeable Staphylococcus aureus","volume":"59","author":"Cocchiaro","year":"2006","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.tips.2015.11.008_bib0475","doi-asserted-by":"crossref","first-page":"e02585","DOI":"10.1128\/mBio.02585-14","article-title":"USA300 and USA500 clonal lineages of Staphylococcus aureus do not produce a capsular polysaccharide due to conserved mutations in the cap5 locus","volume":"6","author":"Boyle-Vavra","year":"2015","journal-title":"MBio"},{"key":"10.1016\/j.tips.2015.11.008_bib0480","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jpeds.2007.04.060","article-title":"Clinical trial of safety and efficacy of INH-A21 for the prevention of nosocomial staphylococcal bloodstream infection in premature infants","volume":"151","author":"DeJonge","year":"2007","journal-title":"J. Pediatr."},{"key":"10.1016\/j.tips.2015.11.008_bib0485","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1128\/AAC.50.2.511-518.2006","article-title":"Human immunoglobulin G recognizing fibrinogen-binding surface proteins is protective against both Staphylococcus aureus and Staphylococcus epidermidis infections in vivo","volume":"50","author":"Vernachio","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.tips.2015.11.008_bib0490","doi-asserted-by":"crossref","first-page":"6864","DOI":"10.1128\/IAI.71.12.6864-6870.2003","article-title":"Characterization of a protective monoclonal antibody recognizing Staphylococcus aureus MSCRAMM protein clumping factor A","volume":"71","author":"Hall","year":"2003","journal-title":"Infect. Immun."},{"issue":"Suppl. 1","key":"10.1016\/j.tips.2015.11.008_bib0495","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1016\/j.vaccine.2004.08.015","article-title":"A humanized monoclonal antibody targeting Staphylococcus aureus","volume":"22","author":"Patti","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.tips.2015.11.008_bib0500","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1128\/AAC.00096-06","article-title":"Phase II, randomized, double-blind, multicenter study comparing the safety and pharmacokinetics of tefibazumab to placebo for treatment of Staphylococcus aureus bacteremia","volume":"50","author":"Weems","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.tips.2015.11.008_bib0505","first-page":"455","article-title":"Drug evaluation: tefibazumab \u2013 a monoclonal antibody against staphylococcal infection","volume":"8","author":"John","year":"2006","journal-title":"Curr. Opin. Mol. Ther."},{"key":"10.1016\/j.tips.2015.11.008_bib0510","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1128\/AAC.01565-08","volume":"53","author":"Weisman","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.tips.2015.11.008_bib0515","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1542\/peds.2010-3081","article-title":"A randomized study of a monoclonal antibody (pagibaximab) to prevent staphylococcal sepsis","volume":"128","author":"Weisman","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.tips.2015.11.008_bib0520","article-title":"Safety and Efficacy of Pagibaximab Injection in Very Low Birth Weight Neonates for Prevention of Staphylococcal Sepsis","author":"Anon.","year":"2011","journal-title":"ClinicalTrials gov"},{"key":"10.1016\/j.tips.2015.11.008_bib0525","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1128\/IAI.68.6.3200-3209.2000","article-title":"Identification of an immunodominant ABC transporter in methicillin-resistant Staphylococcus aureus infections","volume":"68","author":"Burnie","year":"2000","journal-title":"Infect. Immun."},{"key":"10.1016\/j.tips.2015.11.008_bib0530","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1517\/14712598.2010.495115","article-title":"Novel targeted immunotherapy approaches for staphylococcal infection","volume":"10","author":"Otto","year":"2010","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.tips.2015.11.008_bib0535","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1038\/nbt1206-1491","article-title":"Anti-infective antibodies: finding the path forward","volume":"24","author":"Baker","year":"2006","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.tips.2015.11.008_bib0540","series-title":"A Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Pharmacokinetics, Pharmacodynamics, and Safety of a Single Dose of SAR279356 in Patients Hospitalized in Intensive Care Unit and on Mechanical Ventilation","author":"Sanofi","year":"2012"},{"key":"10.1016\/j.tips.2015.11.008_bib0545","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.3390\/toxins5061140","article-title":"Staphylococcus aureus alpha-toxin: nearly a century of intrigue","volume":"5","author":"Berube","year":"2013","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.tips.2015.11.008_bib0550","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1084\/jem.20072208","article-title":"Vaccine protection against Staphylococcus aureus pneumonia","volume":"205","author":"Bubeck Wardenburg","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.tips.2015.11.008_bib0555","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1086\/656043","article-title":"Targeting of alpha-hemolysin by active or passive immunization decreases severity of USA300 skin infection in a mouse model","volume":"202","author":"Kennedy","year":"2010","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.tips.2015.11.008_bib0560","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/infdis\/jis192","article-title":"ADAM10 mediates vascular injury induced by Staphylococcus aureus alpha-hemolysin","volume":"206","author":"Powers","year":"2012","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.tips.2015.11.008_bib0565","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/infdis\/jiu223","article-title":"Targeting Staphylococcus aureus alpha-toxin as a novel approach to reduce severity of recurrent skin and soft-tissue infections","volume":"210","author":"Sampedro","year":"2014","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.tips.2015.11.008_bib0570","doi-asserted-by":"crossref","first-page":"29874","DOI":"10.1074\/jbc.M114.601328","article-title":"Mechanisms of neutralization of a human anti-alpha-toxin antibody","volume":"289","author":"Oganesyan","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2015.11.008_bib0575","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1128\/AAC.02190-13","article-title":"Assessment of an anti-alpha-toxin monoclonal antibody for prevention and treatment of Staphylococcus aureus-induced pneumonia","volume":"58","author":"Hua","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.tips.2015.11.008_bib0580","series-title":"AR-301: Fully Human mAb Against Staphylococcus aureus","year":"2015"},{"key":"10.1016\/j.tips.2015.11.008_bib0585","series-title":"MRSA","year":"2015"},{"key":"10.1016\/j.tips.2015.11.008_bib0590","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1128\/IAI.74.4.2215-2223.2006","article-title":"A novel Staphylococcus aureus vaccine: iron surface determinant B induces rapid antibody responses in rhesus macaques and specific increased survival in a murine S. aureus sepsis model","volume":"74","author":"Kuklin","year":"2006","journal-title":"Infect. Immun."},{"key":"10.1016\/j.tips.2015.11.008_bib0595","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1001\/jama.2013.3010","article-title":"Effect of an investigational vaccine for preventing Staphylococcus aureus infections after cardiothoracic surgery: a randomized trial","volume":"309","author":"Fowler","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.tips.2015.11.008_bib0600","doi-asserted-by":"crossref","first-page":"e46648","DOI":"10.1371\/journal.pone.0046648","article-title":"Opsonic and protective properties of antibodies raised to conjugate vaccines targeting six Staphylococcus aureus antigens","volume":"7","author":"Pozzi","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.tips.2015.11.008_bib0605","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.vaccine.2003.11.034","article-title":"Development of StaphVAX, a polysaccharide conjugate vaccine against S. aureus infection: from the lab bench to phase III clinical trials","volume":"22","author":"Fattom","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.tips.2015.11.008_bib0610","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1128\/CDLI.10.6.1019-1024.2003","article-title":"Multilaboratory evaluation of a viability assay for measurement of opsonophagocytic antibodies specific to the capsular polysaccharides of Streptococcus pneumoniae","volume":"10","author":"Romero-Steiner","year":"2003","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.tips.2015.11.008_bib0615","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1128\/IAI.01444-13","article-title":"Identification of a crucial residue required for Staphylococcus aureus LukAB cytotoxicity and receptor recognition","volume":"82","author":"DuMont","year":"2014","journal-title":"Infect. Immun."},{"key":"10.1016\/j.tips.2015.11.008_bib0620","doi-asserted-by":"crossref","first-page":"3907","DOI":"10.4049\/jimmunol.175.6.3907","article-title":"Insights into mechanisms used by Staphylococcus aureus to avoid destruction by human neutrophils","volume":"175","author":"Voyich","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.tips.2015.11.008_bib0625","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.4049\/jimmunol.164.7.3713","article-title":"Survival of Staphylococcus aureus inside neutrophils contributes to infection","volume":"164","author":"Gresham","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.tips.2015.11.008_bib0630","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1111\/cmi.12130","article-title":"Staphylococcal alpha-phenol soluble modulins contribute to neutrophil lysis after phagocytosis","volume":"15","author":"Surewaard","year":"2013","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.tips.2015.11.008_bib0635","doi-asserted-by":"crossref","first-page":"500","DOI":"10.4049\/jimmunol.180.1.500","article-title":"Neutrophil microbicides induce a pathogen survival response in community-associated methicillin-resistant Staphylococcus aureus","volume":"180","author":"Palazzolo-Balance","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.tips.2015.11.008_bib0640","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1128\/IAI.00095-13","article-title":"Staphylococcus aureus elaborates leukocidin AB to mediate escape from within human neutrophils","volume":"81","author":"DuMont","year":"2013","journal-title":"Infect. Immun."},{"key":"10.1016\/j.tips.2015.11.008_bib0645","doi-asserted-by":"crossref","first-page":"e1004970","DOI":"10.1371\/journal.ppat.1004970","article-title":"Staphylococcus aureus leukocidin A\/B (LukAB) kills human monocytes via host NLRP3 and ASC when extracellular, but not intracellular","volume":"11","author":"Melehani","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.tips.2015.11.008_bib0650","doi-asserted-by":"crossref","first-page":"4146","DOI":"10.1128\/IAI.65.10.4146-4151.1997","article-title":"Protective efficacy of antibodies to the Staphylococcus aureus type 5 capsular polysaccharide in a modified model of endocarditis in rats","volume":"65","author":"Lee","year":"1997","journal-title":"Infect. Immun."},{"key":"10.1016\/j.tips.2015.11.008_bib0655","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1093\/infdis\/jis495","article-title":"Staphylococcus aureus Leukotoxin GH promotes inflammation","volume":"206","author":"Malachowa","year":"2012","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.tips.2015.11.008_bib0660","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.chom.2013.04.006","article-title":"The staphylococcal toxin Panton-Valentine Leukocidin targets human C5a receptors","volume":"13","author":"Spaan","year":"2013","journal-title":"Cell Host Microbe."},{"key":"10.1016\/j.tips.2015.11.008_bib0665","doi-asserted-by":"crossref","first-page":"e1000715","DOI":"10.1371\/journal.ppat.1000715","article-title":"Staphylococcus aureus Panton-Valentine leukocidin is a very potent cytotoxic factor for human neutrophils","volume":"6","author":"Loffler","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.tips.2015.11.008_bib0670","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1146\/annurev-micro-092412-155711","article-title":"Subterfuge and sabotage: evasion of host innate defenses by invasive gram-positive bacterial pathogens","volume":"68","author":"Okumura","year":"2014","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.tips.2015.11.008_bib0675","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1038\/nrmicro1289","article-title":"Immune evasion by staphylococci","volume":"3","author":"Foster","year":"2005","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.tips.2015.11.008_bib0680","doi-asserted-by":"crossref","first-page":"e38407","DOI":"10.1371\/journal.pone.0038407","article-title":"Staphylococcus aureus surface protein SdrE binds complement regulator factor H as an immune evasion tactic","volume":"7","author":"Sharp","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.tips.2015.11.008_bib0685","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/j.molimm.2007.10.021","article-title":"S. aureus IgG-binding proteins SpA and Sbi: host specificity and mechanisms of immune complex formation","volume":"45","author":"Atkins","year":"2008","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.tips.2015.11.008_bib0690","doi-asserted-by":"crossref","first-page":"212","DOI":"10.4161\/mabs.2.3.11780","article-title":"Cleavage of IgGs by proteases associated with invasive diseases: an evasion tactic against host immunity?","volume":"2","author":"Brezski","year":"2010","journal-title":"MAbs"},{"key":"10.1016\/j.tips.2015.11.008_bib0695","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3389\/fcimb.2012.00052","article-title":"Staphylococcal superantigens in colonization and disease","volume":"2","author":"Xu","year":"2012","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.tips.2015.11.008_bib0700","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1128\/MMBR.00055-13","article-title":"The bicomponent pore-forming leucocidins of Staphylococcus aureus","volume":"78","author":"Alonzo","year":"2014","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.tips.2015.11.008_bib0705","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/jid.2012.347","article-title":"High anti-staphylococcal antibody titers in patients with epidermolysis bullosa relate to long-term colonization with alternating types of Staphylococcus aureus","volume":"133","author":"van der Kooi-Pol","year":"2013","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.tips.2015.11.008_bib0710","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1111\/j.1462-5822.2010.01506.x","article-title":"A novel staphylococcal internalization mechanism involves the major autolysin Atl and heat shock cognate protein Hsc70 as host cell receptor","volume":"12","author":"Hirschhausen","year":"2010","journal-title":"Cell Microbiol."},{"key":"10.1016\/j.tips.2015.11.008_bib0715","doi-asserted-by":"crossref","first-page":"6715","DOI":"10.1074\/jbc.M114.630715","article-title":"Mechanisms mediating enhanced neutralization efficacy of staphylococcal enterotoxin B by combinations of monoclonal antibodies","volume":"290","author":"Dutta","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2015.11.008_bib0720","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1093\/infdis\/jir389","article-title":"Methicillin-susceptible Staphylococcus aureus endocarditis isolates are associated with clonal complex 30 genotype and a distinct repertoire of enterotoxins and adhesins","volume":"204","author":"Nienaber","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.tips.2015.11.008_bib0725","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature13777","article-title":"Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp","volume":"514","author":"Qiu","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.tips.2015.11.008_bib0730","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1128\/AAC.04433-14","article-title":"Broad coverage of genetically diverse strains of Clostridium difficile by actoxumab and bezlotoxumab predicted by in vitro neutralization and epitope modeling","volume":"59","author":"Hernandez","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.tips.2015.11.008_bib0735","doi-asserted-by":"crossref","first-page":"3680","DOI":"10.1073\/pnas.1424924112","article-title":"Composition formulated with a novel TLR7-dependent adjuvant induces high and broad protection against Staphylococcus aureus","volume":"112","author":"Bagnoli","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tips.2015.11.008_bib0740","doi-asserted-by":"crossref","first-page":"243","DOI":"10.4161\/19420862.2014.985132","article-title":"Five birds, one stone: neutralization of alpha-hemolysin and 4 bi-component leukocidins of Staphylococcus aureus with a single human monoclonal antibody","volume":"7","author":"Rouha","year":"2015","journal-title":"MAbs"},{"key":"10.1016\/j.tips.2015.11.008_bib0745","doi-asserted-by":"crossref","first-page":"25203","DOI":"10.1074\/jbc.M112.364075","article-title":"Synthetic human monoclonal antibodies toward staphylococcal enterotoxin B (SEB) protective against toxic shock syndrome","volume":"287","author":"Karauzum","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2015.11.008_bib0750","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1128\/IAI.00230-12","article-title":"Protein A-specific monoclonal antibodies and prevention of Staphylococcus aureus disease in mice","volume":"80","author":"Kim","year":"2012","journal-title":"Infect. Immun."},{"key":"10.1016\/j.tips.2015.11.008_bib0755","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.vaccine.2014.11.051","article-title":"Protein A-neutralizing monoclonal antibody protects neonatal mice against Staphylococcus aureus","volume":"33","author":"Thammavongsa","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.tips.2015.11.008_bib0760","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1002\/jor.22672","article-title":"Passive immunization with anti-glucosaminidase monoclonal antibodies protects mice from implant-associated osteomyelitis by mediating opsonophagocytosis of Staphylococcus aureus megaclusters","volume":"32","author":"Varrone","year":"2014","journal-title":"J. Orthop. Res."},{"key":"10.1016\/j.tips.2015.11.008_bib0765","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ijmm.2014.11.002","article-title":"A human monoclonal antibody targeting the conserved staphylococcal antigen IsaA protects mice against Staphylococcus aureus bacteremia","volume":"305","author":"van den Berg","year":"2015","journal-title":"Int. J. Med. Microbiol."},{"key":"10.1016\/j.tips.2015.11.008_bib0770","unstructured":"Brown E.J. et al. Genentech Inc. Anti-wall teichoic antibodies and conjugates, WO 2014194247 A1"},{"key":"10.1016\/j.tips.2015.11.008_bib0775","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nature16057","article-title":"Novel antibody\u2013antibiotic conjugate eliminates intracellular S. aureus","volume":"527","author":"Lehar","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.tips.2015.11.008_bib0780","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/protein\/gzr064","article-title":"Design of novel FN3 domains with high stability by a consensus sequence approach","volume":"25","author":"Jacobs","year":"2012","journal-title":"Protein Eng. Des. Sel."},{"key":"10.1016\/j.tips.2015.11.008_bib0785","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1093\/protein\/gzu016","article-title":"Selection of high-affinity Centyrin FN3 domains from a simple library diversified at a combination of strand and loop positions","volume":"27","author":"Diem","year":"2014","journal-title":"Protein Eng. Des. Sel."},{"key":"10.1016\/j.tips.2015.11.008_bib0790","unstructured":"Torres, V.J. et al. New York University and Janssen Biotech Inc. Compositions and methods for phagocyte delivery of antistaphylococcal agents, 20150210756 A1"},{"key":"10.1016\/j.tips.2015.11.008_bib0795","doi-asserted-by":"crossref","first-page":"16404","DOI":"10.1073\/pnas.1102265108","article-title":"Heavy chain-only antibodies and tetravalent bispecific antibody neutralizing Staphylococcus aureus leukotoxins","volume":"108","author":"Laventie","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."}],"container-title":["Trends in Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614715002448?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614715002448?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,12]],"date-time":"2020-09-12T23:08:24Z","timestamp":1599952104000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165614715002448"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":80,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S0165614715002448"],"URL":"https:\/\/doi.org\/10.1016\/j.tips.2015.11.008","relation":{},"ISSN":["0165-6147"],"issn-type":[{"value":"0165-6147","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibody-Based Biologics and Their Promise to Combat Staphylococcus aureus Infections","name":"articletitle","label":"Article Title"},{"value":"Trends in Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tips.2015.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}